Inhibition of the IL-6 signaling pathway: a strategy to combat chronic inflammatory diseases and cancer

P Ataie-Kachoie, MH Pourgholami, DL Morris - Cytokine & growth factor …, 2013 - Elsevier
Interleukin (IL)-6 is a pro-inflammatory cytokine that produces multifunctional effects.
Deregulated IL-6 production and signaling are associated with chronic inflammatory …

Aberrant expression of interleukin-1β and inflammasome activation in human malignant gliomas

L Tarassishin, D Casper, SC Lee - PloS one, 2014 - journals.plos.org
Objective Glioblastoma is the most frequent and malignant form of primary brain tumor with
grave prognosis. Mounting evidence supports that chronic inflammation (such as chronic …

IL-6 mediates cross-talk between tumor cells and activated fibroblasts in the tumor microenvironment

TA Karakasheva, EW Lin, Q Tang, E Qiao, TJ Waldron… - Cancer Research, 2018 - AACR
The tumor microenvironment (TME) plays a major role in the pathogenesis of multiple
cancer types, including upper-gastrointestinal (GI) cancers that currently lack effective …

Expression of interleukin‐1β in human breast carcinoma

L Jin, RQ Yuan, A Fuchs, Y Yao… - … Journal of the …, 1997 - Wiley Online Library
The authors report that significant titers of the proinflammatory cytokine interleukin‐1β (IL‐
1β) are present within the microenvironment of most breast carcinomas. A high IL‐1β …

Interleukin-17 acts as double-edged sword in anti-tumor immunity and tumorigenesis

X Qian, H Chen, X Wu, L Hu, Q Huang, Y Jin - Cytokine, 2017 - Elsevier
Abstract Interleukin-17 (IL-17), a proinflammatory cytokine, mainly produced by Th17 cells,
participates in both innate and adaptive immune responses and is involved in various …

Therapeutic targeting of IL-6 trans-signaling

S Rose-John - Cytokine, 2021 - Elsevier
Abstract Interleukin-6 (IL-6) is a cytokine, which is involved in innate and acquired immunity,
in neural cell maintenance and in metabolism. IL-6 can be synthesized by many different …

Mechanism of action of IL-7 and its potential applications and limitations in cancer immunotherapy

J Gao, L Zhao, YY Wan, B Zhu - International journal of molecular …, 2015 - mdpi.com
Interleukin-7 (IL-7) is a non-hematopoietic cell-derived cytokine with a central role in the
adaptive immune system. It promotes lymphocyte development in the thymus and maintains …

Abolished angiogenicity and tumorigenicity of Burkitt lymphoma by interleukin-10

L Cervenak, L Morbidelli, D Donati… - Blood, The Journal …, 2000 - ashpublications.org
Because of its immunosuppressive properties, interleukin-10 (IL-10) is thought to play an
important role in a number of human disease states, including inflammation, autoimmunity …

Interleukin-2: clinical applications

MB Atkins - Seminars in oncology, 2002 - Elsevier
Interleukin-2 (IL-2) is a promising immunotherapeutic agent for the treatment of metastatic
melanoma, acute myelogenous leukemia, and metastatic renal cell carcinoma. While high …

Versatile functions for IL-6 in metabolism and cancer

J Mauer, JL Denson, JC Brüning - Trends in immunology, 2015 - cell.com
Owing to its abundance in inflammatory settings, interleukin IL-6 is frequently viewed as a
proinflammatory cytokine, with functions that parallel those of tumor necrosis factor (TNF) …